{
  "metadata": {
    "key": "page:https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39606732",
    "created": 1769901289.052377,
    "ttl": 604800
  },
  "data": "WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking. - National Genomics Data Center (CNCB-NGDC) OpenLB Open Library of Bioscience Search Advanced Search Source: PubMed ArXiv Nov 14, 2024; WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking. Yunchao Lance Liu, Ha Dong, Xin Wang, Rocco Moretti, Yu Wang, Zhaoqian Su, Jiawei Gu, Bobby Bodenheimer, Charles David Weaver, Jens Meiler, Tyler Derr Author Information Yunchao Lance Liu: Computer Science Dept., Vanderbilt University (VU). Ha Dong: Neural Science Dept., Amherst College. Xin Wang: Computer Science Dept., Vanderbilt University (VU). Rocco Moretti: Chemistry Dept., VU. Yu Wang: Computer Science Dept., University of Oregon. Zhaoqian Su: Data Science Institute, VU. Jiawei Gu: MD Anderson Cancer Center. Bobby Bodenheimer: Computer Science Dept., Vanderbilt University (VU). Charles David Weaver: Chemistry Dept., VU. Jens Meiler: Chemistry Dept., VU. Tyler Derr: Computer Science Dept., Vanderbilt University (VU). PMID: 39606732 Abstract 中文译文 English While deep learning has revolutionized computer-aided drug discovery, the AI community has predominantly focused on model innovation and placed less emphasis on establishing best benchmarking practices. We posit that without a sound model evaluation framework, the AI community's efforts cannot reach their full potential, thereby slowing the progress and transfer of innovation into real-world drug discovery. Thus, in this paper, we seek to establish a new gold standard for small molecule drug discovery benchmarking, . Specifically, our contributions are threefold: - we introduce a meticulously curated collection of 9 datasets spanning 5 therapeutic target classes. Our hierarchical curation pipelines, designed by drug discovery experts, go beyond the primary high-throughput screen by leveraging additional confirmatory and counter screens along with rigorous domain-driven preprocessing, such as Pan-Assay Interference Compounds (PAINS) filtering, to ensure the high-quality data in the datasets; - we propose a standardized model evaluation framework considering high-quality datasets, featurization, 3D conformation generation, evaluation metrics, and data splits, which provides a reliable benchmarking for drug discovery experts conducting real-world virtual screening; - we evaluate model performance through various research questions using the dataset collection, exploring the effects of different models, dataset quality, featurization methods, and data splitting strategies on the results. In summary, we recommend adopting our proposed as the gold standard in small molecule drug discovery benchmarking. The dataset collection, along with the curation codes, and experimental scripts are all publicly available at WelQrate.org. References J Med Chem. 2010 Apr 8;53(7):2719-40 [PMID: 20131845 ] J Chem Inf Model. 2010 Jul 26;50(7):1189-204 [PMID: 20572635 ] J Med Chem. 2017 Feb 23;60(4):1238-1246 [PMID: 28001064 ] Molecules. 2013 Jan 08;18(1):735-56 [PMID: 23299552 ] Beilstein J Org Chem. 2016 Dec 12;12:2694-2718 [PMID: 28144341 ] J Med Chem. 2013 Sep 12;56(17):6560-72 [PMID: 23688234 ] J Med Chem. 1996 Jul 19;39(15):2887-93 [PMID: 8709122 ] J Chem Phys. 2018 Jun 28;148(24):241722 [PMID: 29960322 ] J Med Chem. 2001 Feb 15;44(4):502-11 [PMID: 11170640 ] J Med Chem. 2004 Mar 25;47(7):1750-9 [PMID: 15027866 ] Front Pharmacol. 2022 Feb 21;13:833099 [PMID: 35264967 ] Nucleic Acids Res. 2019 Jan 8;47(D1):D1102-D1109 [PMID: 30371825 ] Drug Discov Today Technol. 2010 Winter;7(4):e203-70 [PMID: 24103800 ] Chem Inform. 2017;3(1): [PMID: 29795804 ] Chem Sci. 2017 Oct 31;9(2):513-530 [PMID: 29629118 ] Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26 [PMID: 11259830 ] Pharmacol Rev. 2013 Dec 31;66(1):334-95 [PMID: 24381236 ] Front Mol Biosci. 2022 May 23;9:863099 [PMID: 35677880 ] J Comput Aided Mol Des. 2016 Mar;30(3):209-17 [PMID: 26721261 ] J Cheminform. 2015 May 30;7:23 [PMID: 26136848 ] Grants R01 DA046138/NIDA NIH HHS R01 GM080403/NIGMS NIH HHS R01 HL122010/NHLBI NIH HHS Journal Article Preprint Word Cloud WelQrate: Defining Gold Standard Small Molecule Drug Discovery Benchmarking.\" style=\"background-color: #f5f5f5\"> Similar Articles Cited By"
}